Condition
    Preliminary
    Effectiveness 2/5

    Omega-3 Fatty Acids for Traumatic Brain Injury

    The animal data on DHA after brain injury are genuinely impressive, and the human outcome evidence essentially does not exist.

    Overview

    The animal data on DHA after brain injury are genuinely impressive, and the human outcome evidence essentially does not exist.

    Verdict

    Insufficient evidence

    Insufficient evidence. Strong preclinical rationale with no adequate human outcome trials.

    How It Works

    DHA is a major structural component of neuronal membranes and gives rise to resolvins and neuroprotectins, specialised mediators that actively terminate neuroinflammation and support axonal repair after injury.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1-2g combined EPA/DHA daily with food
    Expected timeframe
    8-12 weeks; no demonstrated effect on recovery time

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: the neuroprotective data for omega-3 in traumatic brain injury come from animal models and case reports, not controlled human trials. Doses of 1-3 g/day combined EPA+DHA studied in other settings produced no TBI recovery outcomes. Rehabilitation, sleep restoration, headache management and graded return to activity are what change outcomes.
    titration
    Not applicable
    starting dose
    Not applicable as an established treatment

    Evidence

    What the studies say

    Rodent models of controlled cortical impact and diffuse axonal injury consistently show that DHA supplementation reduces axonal damage markers, limits neuroinflammation and improves behavioural outcomes, and these findings are reproducible enough that they are frequently cited in support of human use. That translation has not been demonstrated. Human trials are small, often uncontrolled case series in athletes, with heterogeneous dosing and outcome measures, and no adequately powered randomised trial has shown faster symptom resolution or better functional outcome after concussion. A blood biomarker trial in American football players showed reduced neurofilament light with high-dose DHA, which is a mechanistic signal rather than a clinical outcome. The interventions with actual randomised support in concussion are graded sub-threshold aerobic exercise, sleep management and targeted vestibular and cervical rehabilitation.

    Nutritional Supplement and Dietary Interventions as a Prophylaxis or Treatment of Sub-Concussive Repetitive Head Impact and Mild Traumatic Brain Injury: A Systematic Review

    Score: 6/10
    2023
    systematic_review
    n=1139

    Feinberg C

    Strongest evidence supports n-3FA utility for neurotrauma prevention in athletes exposed to SRHI.

    View source

    Safety

    Caveats

    Additive bleeding risk with anticoagulants and antiplatelets — relevant in head injury, where intracranial bleeding is the main acute concern. Do not start high-dose omega-3 in the acute phase without medical advice.

    Less likely to help if

    Everyone, in the sense that no human outcome benefit has been established for any subgroup.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.